Journal of Clinical and Aesthetic Dermatology

Plaque-type Psoriasis Supplement 2016

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: http://jcadonline.epubxp.com/i/691107

Contents of this Issue

Navigation

Page 9 of 15

S10 SUPPLEMENT TO THE JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY [JUNE 2016 • VOLUME 9 • NUMBER 6 • SUPPLEMENT 1] Figure 2. Speed of Response in the FIXTURE study. This figure shows median time to 50% reduction in the mean PASI score in the secukinumab and etanercept arms. Adapted from Langley et al. N Engl J Med. 2014;371(4):326–338. Figure 3. Efficacy through Week 52 in the FIXTURE study. This figure shows maintenance of response with regards to PASI 75, 90, and 100, and IGA 0 or 1 in secukinumab 300mg and150mg groups and etanercept group through Week 52. Adapted from Langley et al. N Engl J Med. 2014;371(4):326–338.

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - Plaque-type Psoriasis Supplement 2016